Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Watch on Radcliffe Cardiology:

Following the announcement of Medtronic's acquisition of Affera, here Rebecca Seidel, President, Cardiac Ablation Solutions, Medtronic discusses the burden presented by cardiac arrhythmias, the strategic appeal of Affera's portfolio, the perceived real-world benefits of the system, and the remaining challenges for better patient care.

Discussion Points:
1. The prevalence of cardiac arrhythmias
2. Innovation of the Affera portfolio
3. Driving factors for the acquisition
4. On the comment by Doron Harlev, CEO of Affera, that the platform has a physician- and patient-centred design
5. Ongoing SPHERE Per-AF trial
6. Real-world patient benefits of system
7. Remaining challenges for treating cardiac arrhythmias

No financial support was provided for the commissioning and publication of this interview. The opinions expressed here are those of the interviewee and not necessarily of Radcliffe Cardiology.

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Чтобы скачать видео "Medtronic Acquires Affera to Add Mapping and Navigation System to Cardiac Ablation Portfolio" передвинте ползунок вправо